TY - STD TI - Gogola E, Rottenberg S, Jonkers J. Resistance to PARP inhibitors: lessons from preclinical models of BRCA-associated cancer. Annu Rev Cancer Biol. 2019; in press. ID - ref1 ER - TY - JOUR AU - Hanzlikova, H. AU - Kalasova, I. AU - Demin, A. A. AU - Pennicott, L. E. AU - Cihlarova, Z. AU - Caldecott, K. W. PY - 2018 DA - 2018// TI - The importance of poly(ADP-ribose) polymerase as a sensor of unligated Okazaki fragments during DNA replication JO - Mol Cell VL - 71 UR - https://doi.org/10.1016/j.molcel.2018.06.004 DO - 10.1016/j.molcel.2018.06.004 ID - Hanzlikova2018 ER - TY - JOUR AU - Liu, H. AU - Zhang, H. AU - Wu, X. AU - Ma, D. AU - Wu, J. AU - Wang, L. PY - 2018 DA - 2018// TI - Nuclear cGAS suppresses DNA repair and promotes tumorigenesis JO - Nature VL - 563 UR - https://doi.org/10.1038/s41586-018-0629-6 DO - 10.1038/s41586-018-0629-6 ID - Liu2018 ER - TY - JOUR AU - Ghezraoui, H. AU - Oliveira, C. AU - Becker, J. R. AU - Bilham, K. AU - Moralli, D. AU - Anzilotti, C. PY - 2018 DA - 2018// TI - 53BP1 cooperation with the REV7–shieldin complex underpins DNA structure-specific NHEJ JO - Nature VL - 560 UR - https://doi.org/10.1038/s41586-018-0362-1 DO - 10.1038/s41586-018-0362-1 ID - Ghezraoui2018 ER - TY - STD TI - Becker JR, Cuella-Martin R, Barazas M, Liu R, Oliveira C, Oliver AW, et al. The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity. Nat Commun. 2019;in press. ID - ref5 ER - TY - JOUR AU - He, Y. J. AU - Meghani, K. AU - Caron, M. C. AU - Yang, C. AU - Ronato, D. A. AU - Bian, J. PY - 2018 DA - 2018// TI - DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells JO - Nature VL - 563 UR - https://doi.org/10.1038/s41586-018-0670-5 DO - 10.1038/s41586-018-0670-5 ID - He2018 ER - TY - JOUR AU - Barazas, M. AU - Annunziato, S. AU - Pettitt, S. J. AU - Krijger, I. AU - Ghezraoui, H. AU - Roobol, S. J. PY - 2018 DA - 2018// TI - The CST complex mediates end-protection at double-strand breaks and promotes PARP inhibitor sensitivity in BRCA1-deficient cells JO - Cell Rep VL - 23 UR - https://doi.org/10.1016/j.celrep.2018.04.046 DO - 10.1016/j.celrep.2018.04.046 ID - Barazas2018 ER - TY - JOUR AU - Mirman, Z. AU - Lottersberger, F. AU - Takai, H. AU - Kibe, T. AU - Gong, Y. AU - Takai, K. PY - 2018 DA - 2018// TI - 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in JO - Nature VL - 560 UR - https://doi.org/10.1038/s41586-018-0324-7 DO - 10.1038/s41586-018-0324-7 ID - Mirman2018 ER - TY - JOUR AU - Gogola, E. AU - Duarte, A. A. AU - Ruiter, J. R. AU - Wiegant, W. W. AU - Schmid, J. A. AU - Bruijn, R. PY - 2018 DA - 2018// TI - Selective loss of PARG restores PARylation and counteracts PARP inhibitor-mediated synthetic lethality JO - Cancer Cell VL - 33 UR - https://doi.org/10.1016/j.ccell.2018.05.008 DO - 10.1016/j.ccell.2018.05.008 ID - Gogola2018 ER - TY - JOUR AU - Dev, H. AU - Chiang, T. W. AU - Lescale, C. AU - Krijger, I. AU - Martin, A. G. AU - Pilger, D. PY - 2018 DA - 2018// TI - Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells JO - Nat Cell Biol VL - 20 UR - https://doi.org/10.1038/s41556-018-0140-1 DO - 10.1038/s41556-018-0140-1 ID - Dev2018 ER - TY - STD TI - Barazas M, Gasparini A, Huang Y, Küçükosmanoğlu A, Annunziato A, Bouwman P, et al. Radiosensitivity is an acquired vulnerability of PARPi-resistant BRCA1-deficient tumors. Cancer Res. 2018. https://doi.org/10.1158/0008-5472.CAN-18-2077. ID - ref11 ER -